Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
REPRO-MED Systems (KRMD) Receives a Buy from Lake Street
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
It Looks Like KORU Medical Systems, Inc.'s (NASDAQ:KRMD) CEO May Expect Their Salary To Be Put Under The Microscope
Craig-Hallum Sticks to Their Buy Rating for REPRO-MED Systems (KRMD)
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic Growth Initiatives
REPRO-MED Systems: Strong Start to Fiscal Year 2024 with Strategic Growth and Consistent Margins
Q1 2024 KORU Medical Systems Inc Earnings Call Transcript
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges
KORU Medical Systems GAAP EPS of -$0.04 in-line, revenue of $8.2M beats by $0.67M
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.